Inhibiting BRD4, either through the BET pharmacological inhibitor JQ1 or BRD4‐specific siRNA, may prevent melanoma cell metastasis by curtailing cell invasion and migration while facilitating the phagocytosis‐mediated elimination of melanoma cells. The gene discussed is BRD4; the disease is melanoma.